JPH03279379A - New compound indanonaphthol a and b - Google Patents
New compound indanonaphthol a and bInfo
- Publication number
- JPH03279379A JPH03279379A JP7967090A JP7967090A JPH03279379A JP H03279379 A JPH03279379 A JP H03279379A JP 7967090 A JP7967090 A JP 7967090A JP 7967090 A JP7967090 A JP 7967090A JP H03279379 A JPH03279379 A JP H03279379A
- Authority
- JP
- Japan
- Prior art keywords
- indanonaphthol
- magnetic resonance
- nuclear magnetic
- methanol
- measured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 45
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 7
- 229910001868 water Inorganic materials 0.000 claims abstract description 7
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims abstract description 4
- 150000001298 alcohols Chemical class 0.000 claims abstract description 4
- 238000000921 elemental analysis Methods 0.000 claims abstract description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 4
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims abstract description 4
- 239000012286 potassium permanganate Substances 0.000 claims abstract description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims description 12
- 241000204849 Hormonema Species 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000862 absorption spectrum Methods 0.000 claims description 8
- YMWUJEATGCHHMB-DICFDUPASA-N dichloromethane-d2 Chemical compound [2H]C([2H])(Cl)Cl YMWUJEATGCHHMB-DICFDUPASA-N 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 241000088427 Hormonema sp. Species 0.000 claims description 5
- 239000003463 adsorbent Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 claims description 4
- 238000004809 thin layer chromatography Methods 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- -1 9-ammonium nitrate Chemical compound 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 230000008117 seed development Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002160 Celluloid Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006783 corn meal agar Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- CZPRKINNVBONSF-UHFFFAOYSA-M zinc;dioxido(oxo)phosphanium Chemical compound [Zn+2].[O-][P+]([O-])=O CZPRKINNVBONSF-UHFFFAOYSA-M 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は抗菌作用を有する新規化合物インダノナフトー
ル(Indanonaftol) AおよびB、並びに
その製法に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to new compounds Indanonaftol A and B having antibacterial activity, and a method for producing the same.
(従来の技術)
従来、ナフタレン骨格を有する化合物およびインデン骨
格を有する化合物は多数知られているが、ナフタレン骨
格とインデン骨格がスピロ結合で結合した化合物は知ら
れていない。(Prior Art) Conventionally, many compounds having a naphthalene skeleton and compounds having an indene skeleton have been known, but a compound in which a naphthalene skeleton and an indene skeleton are bonded through a spiro bond is not known.
(発明が解決しようとする課題)
本発明者らは、海水より分離したホルモネマ(Horm
onema)属に属するSANK 50190株の培養
物から、抗菌作用を有する新規化合物インダノナフトー
ルAおよびBが生産されることを見出して本発明を完成
した。(Problems to be Solved by the Invention) The present inventors have discovered that Hormonema (Hormonema) isolated from seawater
The present invention was completed by discovering that new compounds indanonaphthol A and B, which have antibacterial activity, are produced from a culture of SANK 50190 strain belonging to the genus M. onema.
(課題を解決するための手段)
本発明のインダノナフトールAおよびBは下記の構造式
および性状を有する。(Means for Solving the Problems) Indanonaphthol A and B of the present invention have the following structural formula and properties.
1、インダノナフトールA
1)物質の性状:黄色粉末
2)分子式:C19H1□06
3)分子量: 336 (FAB−MS法により測定
)4)元素分析: (%)
実測値 C66,57H4,37
計算値 C67,86H3,60
5)紫外線吸収スペクトル:λ□。nm(E’、、;)
メタノール中で測定した紫外線吸収スペクトルは、次に
示す通りである。1. Indanonaphthol A 1) Property of substance: yellow powder 2) Molecular formula: C19H1□06 3) Molecular weight: 336 (measured by FAB-MS method) 4) Elemental analysis: (%) Actual value C66,57H4,37 Calculation Value C67,86H3,60 5) Ultraviolet absorption spectrum: λ□. nm(E',,;)
The ultraviolet absorption spectrum measured in methanol is as shown below.
232、260(sh)、 333.3986)1H−
核磁気共鳴スペクトル= (δ: ppm)重ジクロロ
メタン中、内部基準にテトラメチルシランを使用して測
定した核磁気共鳴スペクトル(500MHz)は、次に
示す通りである。232, 260 (sh), 333.3986) 1H-
Nuclear magnetic resonance spectrum = (δ: ppm) The nuclear magnetic resonance spectrum (500 MHz) measured in deuterated dichloromethane using tetramethylsilane as an internal standard is as shown below.
5.01(LH,s)、6.84(LH,dd)、6.
86(1H,d)、6.93(1H,d)、6.94(
1H,d)、6.95 (LH、d)、7.23(LH
,d)、7.57 (LH、dd)、7.67(LH,
dd)、8.64(1H,s)、11.84(1H,5
)7)13c−核磁気共鳴スペクトル=(δ: ppm
)重ジクロロメタン中、内部基準にテトラメチルシラン
を使用して測定した核磁気共鳴スペクトル(125,6
MHz)は、次に示す通りである。5.01 (LH, s), 6.84 (LH, dd), 6.
86 (1H, d), 6.93 (1H, d), 6.94 (
1H, d), 6.95 (LH, d), 7.23 (LH
, d), 7.57 (LH, dd), 7.67 (LH,
dd), 8.64 (1H, s), 11.84 (1H, 5
)7) 13c-nuclear magnetic resonance spectrum = (δ: ppm
) Nuclear magnetic resonance spectrum (125,6
MHz) is as shown below.
66.60(d)、73.41(s)、 114.57
(s)、116.62(d)、118.40(d)、1
18.84(d)、120.22(d)、122.82
(s)、126.62(d)、132.93(d)、1
37.73(s)、139.66(d)、140.13
(d)、151.03(s)、157.26(s)、1
63.22(s)、 198.04(s)、 19
8.36(s)、8)溶解性:
メタノール、エタノール、プロパノール、ブタノール等
のアルコール類、ジメチルスルホキシド、ジメチルホル
ムアミド、クロロホルム、酢酸エチル、アセトン、エチ
ルエーテルに可溶、n−ヘキサン、水に不溶。66.60(d), 73.41(s), 114.57
(s), 116.62(d), 118.40(d), 1
18.84(d), 120.22(d), 122.82
(s), 126.62(d), 132.93(d), 1
37.73(s), 139.66(d), 140.13
(d), 151.03(s), 157.26(s), 1
63.22(s), 198.04(s), 19
8.36(s), 8) Solubility: Soluble in alcohols such as methanol, ethanol, propanol, butanol, dimethyl sulfoxide, dimethyl formamide, chloroform, ethyl acetate, acetone, ethyl ether, insoluble in n-hexane and water. .
9)呈色反応:
硫酸、ヨード、過マンガン酸カリウム、塩化第二鉄反応
に陽性。9) Color reaction: Positive for sulfuric acid, iodine, potassium permanganate, and ferric chloride reactions.
10)薄層クロマトグラフイm: Rf値; 0.54 吸着剤;シリカゲル(メルク社製、Art。10) Thin layer chromatography: Rf value; 0.54 Adsorbent: Silica gel (manufactured by Merck & Co., Ltd., Art.
5715)
l展開溶剤;ジクロロメタン:メタノール=90:10
2、インダノナフトールB
1)構造式
2)物質の性状:黄色粉末
3)比旋光度= [α]古5−90.4° (C11,
0、MeOH)
4)分子式:C,H1□○6
5)分子量: 336 (EI−MS法により測定)
6)元素分析: (%) (但し、Ct s H1
20s・H2Oとして)
実測値 C63,14H3,86
計算値 C64,41H3,98
7)紫外線吸収スペクトル:λmaxnm (E:Jメ
タノール中で測定した紫外線吸収スペクトルは、次に示
す通りである。(C11,
0, MeOH) 4) Molecular formula: C, H1□○6 5) Molecular weight: 336 (measured by EI-MS method)
6) Elemental analysis: (%) (However, Ct s H1
20s·H2O) Actual value C63,14H3,86 Calculated value C64,41H3,98 7) Ultraviolet absorption spectrum: λmaxnm (E:J The ultraviolet absorption spectrum measured in methanol is as shown below.
227、313.339.351
8)1H−核磁気共鳴スペクトル: (δ: ppm)
重ジメチルスルホキシド中、内部基準にテトラメチルシ
ランを使用して測定した核磁気共鳴スペクトル(270
MHz)は、次に示す通りである。227, 313.339.351 8) 1H-nuclear magnetic resonance spectrum: (δ: ppm)
Nuclear magnetic resonance spectrum (270
MHz) is as shown below.
5.21(1H,s)、6.77(1H,d)、 6.
96(1H,d)、7.11(1H,t)、7.14(
1H,d)、 7.25(1H,d)、7.28(1H
,d)、7.40(1H,d)、7.67(1H,t)
、9)13C−核磁気共鳴スペクトル: (δ: pp
m)重ジメチルスルホキシド中、内部基準にテトラメチ
ルシランを使用して測定した核磁気共鳴スペクトル(4
00MHz)は、次に示す通りである。5.21 (1H, s), 6.77 (1H, d), 6.
96 (1H, d), 7.11 (1H, t), 7.14 (
1H, d), 7.25 (1H, d), 7.28 (1H
, d), 7.40 (1H, d), 7.67 (1H, t)
, 9) 13C-nuclear magnetic resonance spectrum: (δ: pp
m) Nuclear magnetic resonance spectrum measured in deuterated dimethyl sulfoxide using tetramethylsilane as an internal standard (4
00MHz) is as shown below.
70.8. 108.2.110.1.112.0.1
13.6゜115.9.116.2.118.6.11
8.9.121.0゜124.3.131.6.138
.3.140.9.142.5゜151.2.152.
7.156.8.189.610)赤外線吸収スペクト
ルニジmax Cm ’臭化カリウム(KBr)錠剤法
で測定した赤外線吸収スペクトルは、次に示す通りであ
る。70.8. 108.2.110.1.112.0.1
13.6°115.9.116.2.118.6.11
8.9.121.0゜124.3.131.6.138
.. 3.140.9.142.5゜151.2.152.
7.156.8.189.610) Infrared absorption spectrum Niji max Cm' The infrared absorption spectrum measured by the potassium bromide (KBr) tablet method is as shown below.
3400、1710.1611.1460.1281.
1236゜022
11)溶解性:
メタノール、エタノール、プロパノール、ブタノール等
のアルコール類、ジメチルスルホキシド、ジメチルホル
ムアミド、クロロホルム、酢酸エチル、アセトン、エチ
ルエーテルに可溶、n−ヘキサン、水に不溶。3400, 1710.1611.1460.1281.
1236゜022 11) Solubility: Soluble in alcohols such as methanol, ethanol, propanol, butanol, dimethyl sulfoxide, dimethyl formamide, chloroform, ethyl acetate, acetone, ethyl ether, insoluble in n-hexane and water.
12)呈色反応:
硫酸、ヨード、過マンガン酸カリウム、塩化第二鉄反応
に陽性。12) Color reaction: Positive for sulfuric acid, iodine, potassium permanganate, and ferric chloride reactions.
13)薄層クロマトグラフィー: Rf値; 0.47 吸着剤;シリカゲル(メルク社製、Art。13) Thin layer chromatography: Rf value; 0.47 Adsorbent: Silica gel (manufactured by Merck & Co., Ltd., Art.
5715)
展開溶剤;ジクロロメタン:メタノール=90:10
なお、インダノナフトールAはクロロホルム、酢酸エチ
ル、メタノール等の有機溶剤中ですみやかにインダノナ
フトールBに変換される。5715) Developing solvent; dichloromethane: methanol = 90:10 Indanonaphthol A is quickly converted to indanonaphthol B in an organic solvent such as chloroform, ethyl acetate, or methanol.
本発明のインダノナフトールAおよびBは種々の異性体
を有する。前記式においては、これらの異性体およびこ
れらの異性体の混合物がすべて単一の式で示されている
。従って、本発明においてはこれらの異性体およびこれ
らの異性体の混合物をもすべて含むものである。Indanonaphthol A and B of the present invention have various isomers. In the above formula, all of these isomers and mixtures of these isomers are represented by a single formula. Therefore, the present invention includes all of these isomers and mixtures of these isomers.
本発明のインダノナフトールAおよびBは、常法にした
がって塩とすることができる。そのような塩としては例
えばリチウム、ナトリウム、カリウムのようなアルカリ
金属の塩;カルシウム、バリウムのようなアルカリ土類
金属の塩;アルミニウム塩;リジン、アルギニンのよう
な塩基性アミノ酸の塩;等をあげることができる。好適
には薬理上許容される塩である。Indanonaphthol A and B of the present invention can be converted into salts according to conventional methods. Examples of such salts include salts of alkali metals such as lithium, sodium, and potassium; salts of alkaline earth metals such as calcium and barium; aluminum salts; salts of basic amino acids such as lysine and arginine; etc. I can give it to you. Preferred are pharmacologically acceptable salts.
本発明の、インダノナフトールAおよびBを生産する上
記SANK 50190株は静岡県用奈港の海岸で採取
した海水をポアーサイズ0.45μmのメンブランフィ
ルタ−を用いてろ過し、そのフィルターをYM寒天培地
の上に載せ、23℃で7日間培養し分離したものである
。The SANK 50190 strain of the present invention, which produces indanonaphthol A and B, is obtained by filtering seawater collected from the coast of Yonako, Shizuoka Prefecture using a membrane filter with a pore size of 0.45 μm, and applying the filter to a YM agar medium. The cells were placed on top of the celluloid, cultured at 23°C for 7 days, and then separated.
インダノナフトールAおよびBの生産菌であるSANK
50190株の菌学的性状は次の通りである。SANK, a producer of indanonaphthol A and B
The mycological properties of strain 50190 are as follows.
麦芽エキス寒天培地で24℃で7日間培養したコロニー
の大きさは9 mmであり、同培地で18℃で7日間培
養したコロニーの大きさは17mmである。The size of a colony cultured on a malt extract agar medium at 24°C for 7 days was 9 mm, and the size of a colony cultured on the same medium at 18°C for 7 days was 17 mm.
該コロニーは平滑で、しばしば中心部は盛り上がり、粘
性をおびており、短い気菌糸をまばらに形成する。The colonies are smooth, often with a swollen and sticky center, and sparsely form short aerial hyphae.
コロニーの色は黒、暗いオリーブ灰であり、周縁部は灰
白色である。Colony color is black, dark olive-gray, with gray-white margins.
若い菌糸は透明であるが、生育が進むにつれて褐色とな
り、細胞壁は厚くなる。Young hyphae are transparent, but as they grow, they turn brown and the cell walls become thicker.
菌糸の幅は4〜12μmであり、細胞の幅は縦より長い
。まれに縦に隔壁が入る。菌糸は分枝する。The width of the hyphae is 4 to 12 μm, and the width of the cell is longer than the length. In rare cases, there is a vertical bulkhead. Hyphae are branched.
有性生殖器官は麦芽エキス寒天培地、ジャガイモ・人参
エキス寒天培地、コーンミール寒天培地上では形成しな
い。Sexual reproductive organs do not form on malt extract agar, potato/carrot extract agar, or cornmeal agar.
分生子は未分化の分生子形成母細胞の1ケ所、まれに2
ケ所から押し出し法(basipetal)により形成
される。Conidia are present in one or more rarely two locations in an undifferentiated conidiogenic mother cell.
It is formed by an extrusion method (basipetal) from the beginning.
分生子は楕円形で、その大きさは4〜6×6〜8μmで
あり、表面は平滑である。Conidia are oval in shape, measuring 4 to 6 x 6 to 8 μm, and have a smooth surface.
分生子形成母細胞から離れた分生子は膨張し、厚い細胞
壁を形成することがある。しばしば、この分生子は分裂
し、2個連結する。Conidia detach from the conidiogenic mother cell and may swell and form a thick cell wall. Often, the conidia divide and join together in two.
分生子の発芽は酵母の出芽の様子に似ており、内生胞子
を形成しない。Conidial germination is similar to yeast budding and does not form endospores.
以上の薄形状から既知菌株のそれらと比較検討した結果
、E、J、Hermanides−Nijof著[Au
reobasidium and A11ied Ge
nera、 5tudies in Mycology
。As a result of comparing the above thin shapes with those of known strains, we found that
reobasidium and A11ied Ge
nera, 5 studies in Mycology
.
1977 ]の141項に記載されている分類に従って
本菌をホルモネマ(Hormonema)属に属する菌
株と同定した。しかしながら、ホルモネマ属における種
の定義は未だ明確ではない。したがって、本菌株をホル
モネマーエスピー(Hormonema sp、)
SANK 50190 (微工研菌寄第11359号、
FERM P−11359)と命名した。This bacterium was identified as a strain belonging to the genus Hormonema according to the classification described in Section 141 of [1977]. However, the definition of species in the genus Hormonema is still not clear. Therefore, this strain was classified as Hormonema sp.
SANK 50190 (Feikoken Bibori No. 11359,
FERM P-11359).
なお色調の表示は、日本色彩研究所発行の「色の標準」
に従った。The color tone display is based on the "Color Standard" published by the Japan Color Research Institute.
I followed.
以上、SANK 50190株について説明したが、ホ
ルモネマ属の菌類の諸性質は一定したものではなく、自
然的、人工的に容易に変化することは周知の通りであり
、本発明で使用しうる菌株はホルモネマ属に属するイン
ダノナフトールAおよびBを生産する全ての菌株を包含
するものである。The SANK 50190 strain has been explained above, but it is well known that the properties of fungi of the genus Hormonema are not constant and can easily change naturally or artificially, so the strains that can be used in the present invention are This includes all strains that produce indanonaphthol A and B belonging to the genus Hormonema.
本発明の新規化合物インダノナフトールAおよびBを得
るため、これらの微生物の培養は他の発酵生成物を生産
するために用いられるような培地中で行なわれる。この
ような培地中には、微生物が資化出来る炭素源、窒素源
および無機塩を含有する。To obtain the novel compounds of the invention indanonaphthol A and B, the cultivation of these microorganisms is carried out in media such as those used for producing other fermentation products. Such a medium contains carbon sources, nitrogen sources, and inorganic salts that can be assimilated by microorganisms.
一般に、炭素源としてグルコース、フラクトース、マル
トース、シュークロース、マンニトール、グリセロール
、デキストリン、オート麦、ライ麦、トウモロコシデン
プン、ジャガイモ、トウモロコシ粉、大豆粉、綿実油、
糖蜜、クエン酸、酒石酸などを単一に、あるいは併用し
て用いる事が出来る。一般には、培地量の1−10重量
%で変量する。Generally, carbon sources include glucose, fructose, maltose, sucrose, mannitol, glycerol, dextrin, oats, rye, corn starch, potatoes, corn flour, soybean flour, cottonseed oil,
Molasses, citric acid, tartaric acid, etc. can be used alone or in combination. Generally, it varies from 1 to 10% by weight of the amount of medium.
窒素源としては、一般に蛋白質を含有する物質を発酵工
程に用いる。適当な窒素源としては、大豆粉、フスマ、
落花生粉、綿実油、綿実粉、カゼイン加水分解物、ファ
ーマミン、魚粉、コーンスチープリカー、ペプトン、肉
エキス、イースト、イーストエキス、マルトエキス、硝
酸ナトリウム、硝9アンモニウム、硫酸アンモニウム等
である。As a nitrogen source, substances containing proteins are generally used in the fermentation process. Suitable nitrogen sources include soybean flour, bran,
These include peanut flour, cottonseed oil, cottonseed flour, casein hydrolyzate, firmamine, fishmeal, corn steep liquor, peptone, meat extract, yeast, yeast extract, malt extract, sodium nitrate, 9-ammonium nitrate, ammonium sulfate, and the like.
窒素源は、単一または併用して培地量の0.2−6重量
%の範囲で用いる。The nitrogen source is used singly or in combination in a range of 0.2-6% by weight of the amount of the medium.
培地中に取り入れる栄養無機塩は、ナトリウム、アンモ
ニウム、カルシウム、フォスフェート、サルフェート、
クロライド、カーボネート等のイオンを得ることの出来
る通常の塩類である。また、カリウム、カルシウム、コ
バルト、マンガン、鉄、マグネシウム等の微量の金属も
含む。Nutrient inorganic salts incorporated into the culture medium include sodium, ammonium, calcium, phosphate, sulfate,
These are ordinary salts from which ions such as chloride and carbonate can be obtained. It also contains trace amounts of metals such as potassium, calcium, cobalt, manganese, iron, and magnesium.
液体培養に際しては、消泡剤としてシリコン油、植物油
、界面活性剤等が使用される。For liquid culture, silicone oil, vegetable oil, surfactant, etc. are used as antifoaming agents.
ホルモネマ・エスピー(Hormonema sp、)
SANK50190株を培養しインダノナフトール
AおよびBを生産する培地のpHは、5.0−7.0に
変化させることが出来る。Hormonema sp.
The pH of the medium in which the SANK50190 strain is cultured to produce indanonaphthol A and B can be varied from 5.0 to 7.0.
菌の生育温度は5℃から26℃までであるが15℃から
23℃の範囲が生育良好であり、更にインダノナフトー
ルAおよびBの生産には、18℃から23℃が好適であ
る。The growth temperature of the fungus ranges from 5°C to 26°C, but growth is good in the range of 15°C to 23°C, and 18°C to 23°C is suitable for the production of indanonaphthol A and B.
インダノナフトールAおよびBは、好気的に培養して得
られるが通常用いられる好気的培養法、例えば固体培養
法、振どう培養法、通気攪拌培養法等が用いられる。Indanonaphthol A and B can be obtained by culturing aerobically, and commonly used aerobic culture methods such as solid state culture, shaking culture, aerated agitation culture, etc. can be used.
小規模な培養においては、22℃から23℃で数日間振
どう培養を行うのが良好である。For small-scale cultivation, it is best to culture with shaking at 22°C to 23°C for several days.
培養は三角フラスコ中で、1−2段階の種の発育工程に
より開始する。種発育段階の培地は、炭素源および窒素
源を併用出来る。種フラスコは定温インキュベーター中
で23℃、5日間振とうするか、または充分に成長する
まで振とうする。成長した種は第二の種培地、または生
産培地に接種するのに用いる。中間の発育工程を用いる
場合には、本質的に同様の方法で成長させ、生産培地に
接種するためにそれを部分的に用いる。接種したフラス
コを一定温度で数日間振とうし、インキュベーションが
終わったらフラスコの含有物を遠心分離またはろ過する
。Cultivation begins with a 1-2 stage seed development process in Erlenmeyer flasks. The medium for the seed development stage can contain a combination of carbon and nitrogen sources. Seed flasks are shaken in a constant temperature incubator at 23° C. for 5 days or until full growth. The grown seeds are used to inoculate a second seed medium, or production medium. If an intermediate development step is used, it is grown in essentially the same way and used in part to inoculate the production medium. The inoculated flask is shaken at a constant temperature for several days, and at the end of the incubation the contents of the flask are centrifuged or filtered.
大量培養の場合には、攪拌機、通気装置を付けた適当な
タンクで培養するのが好ましい。この方法によれば、栄
養培地をタンクの中で作成出来る。In the case of large-scale culture, it is preferable to culture in a suitable tank equipped with a stirrer and an aeration device. According to this method, a nutrient medium can be created in a tank.
栄養培地を125℃まで加熱して滅菌し、冷却後、滅菌
培地にあらかじめ成長させてあった種を接種する。培養
は22℃で通気攪拌して行う。この方法は、多量の化合
物を得るのに適している。The nutrient medium is sterilized by heating to 125° C., and after cooling, the sterile medium is inoculated with previously grown seeds. Cultivation is carried out at 22°C with aeration and stirring. This method is suitable for obtaining large amounts of compounds.
培養の経過に伴って生産されるインダノナフトールAお
よびBの量の経時変化は、高速液体クロマトグラフィー
を用いて測定することが出来る。通常は、72時間から
150時間の培養でインダノナフトールAおよびBの生
産量は最高値に達する。Changes over time in the amounts of indanonaphthol A and B produced over the course of culture can be measured using high performance liquid chromatography. Normally, the production of indanonaphthol A and B reaches its maximum value after 72 to 150 hours of culture.
培養終了後、培養液中の液体部分及び菌体内に存在する
インダノナフトールAおよびBは、菌体、その他の固形
部分を珪藻土をろ過動剤とする、ろ過操作または遠心分
離によって分別し、そのろ液または上滑中および菌体中
に存在するインダノナフトールAおよびBを、その物理
化学的性状を利用し抽出精製することにより得られる。After culturing, the liquid part in the culture solution and indanonaphthol A and B present in the bacterial bodies are separated from the bacterial bodies and other solid parts by a filtration operation or centrifugation using diatomaceous earth as a filtering agent. It is obtained by extracting and purifying indanonaphthol A and B present in the filtrate or supernatant and in the bacterial cells using their physicochemical properties.
例えば、ろ液または、上滑中に存在するインダノナフト
ールAおよびBは、酸性PH条件下で水と混和しない有
機溶剤、例えば酢酸エチル、クロロホルム、塩化エチレ
ン、塩化メチレンなどの単独または、それらの組み合わ
せにより抽出精製することができる。あるいは吸着剤と
して、例えば活性炭または吸着用樹脂であるアンバーラ
イトXAD−2゜XAD−4(ローム・アンド・ハース
社製)等や、ダイアイオンHP−10,HP−20,C
HP−20、HP−50(三菱化成(株)製)等が使用
される。インダノナフトールAおよびBを含む液を上記
のごとき吸着剤の層を通過させて不純物を吸着させて取
り除くか、またはインダノナフトールAおよびBを吸着
させた後、メタノール水、アセトン水、n−ブタノール
水などを用いて溶出させることにより得られる。また、
菌体内に存在するインダノナフトールAおよびBは、5
0−90%の含水アセトンまたは含水メタノールにより
抽出し有機溶剤を除去した後、ろ液と同様な抽出精製操
作を行なうことにより得られる。For example, the indanonaphthols A and B present in the filtrate or supernatant may be used alone or in combination with organic solvents that are immiscible with water under acidic PH conditions, such as ethyl acetate, chloroform, ethylene chloride, methylene chloride, etc. Extraction and purification can be achieved by combination. Alternatively, as an adsorbent, for example, activated carbon or adsorption resin Amberlite
HP-20, HP-50 (manufactured by Mitsubishi Kasei Corporation), etc. are used. A liquid containing indanonaphthol A and B is passed through a layer of adsorbent as described above to adsorb and remove impurities, or after adsorbing indanonaphthol A and B, methanol water, acetone water, n- It can be obtained by elution using butanol water or the like. Also,
Indanonaphthol A and B present in the bacterial body are 5
It is obtained by extracting with 0-90% aqueous acetone or aqueous methanol and removing the organic solvent, and then performing the same extraction and purification operation as the filtrate.
このようにして得られたインダノナフトールAおよびB
は、更にシリカゲル、マグネシウム−シリカゲル系のフ
ロリジルのような担体を用いた吸着力ラムクロマトグラ
フィー、 セファデックスLH−20(ファルマシア社
製)などを用いた分配カラムクロマトグラフィー、およ
び順相、逆相力ラムを用いた高速液体クロマトグラフィ
ー等で精製することが出来る。Indanonaphthol A and B thus obtained
Furthermore, adsorption force ram chromatography using carriers such as silica gel and magnesium-silica gel-based Florisil, partition column chromatography using Sephadex LH-20 (manufactured by Pharmacia), and normal phase and reverse phase force chromatography. It can be purified by high performance liquid chromatography using ram.
以上の分離、精製の手段を単独または適宜組み合わせ反
復用いることによりインダノナフトールAおよびBを分
離精製することができる。Indanonaphthol A and B can be separated and purified by repeatedly using the above separation and purification means alone or in appropriate combinations.
本発明のインダノナフトールAおよびBは、文献未載の
新規化合物であり、動物(例、ヒト、イヌ、ネコ、ウサ
ギ等)において、グラム陽性細菌に対し抗菌作用を示す
ことから、各種細菌感染症を対照とする抗菌剤として有
用である。Indanonaphthol A and B of the present invention are new compounds that have not been described in any literature, and exhibit antibacterial activity against Gram-positive bacteria in animals (e.g., humans, dogs, cats, rabbits, etc.), and therefore are effective against various bacterial infections. It is useful as an antibacterial agent for controlling diseases.
本発明のインダノナフトールAおよびBを医薬として用
いる場合、常法に従ってそれ自体または適宜の薬学的に
許容される担体、賦形剤、希釈剤と混合し、粉末、顆粒
、錠剤、カプセル剤、注射剤などの形態で経口的または
非経口的に安全に投与することが出来る。投与量は対象
疾患、投与経路および投与回数などにより異なるが、例
えば成人に対しては1日100 mgから2000 m
gを、症状に応じて1回または数回に分けて投与するの
が好ましい。When indanonaphthol A and B of the present invention are used as a medicine, they can be prepared by themselves or mixed with appropriate pharmaceutically acceptable carriers, excipients, and diluents according to a conventional method, and prepared into powders, granules, tablets, capsules, etc. It can be safely administered orally or parenterally in the form of an injection. The dosage varies depending on the target disease, route of administration, frequency of administration, etc., but for example, for adults, 100 mg to 2000 mg per day.
It is preferable to administer g once or in divided doses depending on the symptoms.
(実施例)
次に実施例をあげて本発明を更に具体的に説明するが、
本発明はこれらに限定されるものではない。(Example) Next, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited to these.
実施例1.インダノナフトールB
A)培養
ホルモネマ・エスピー・SANK 50190株を、無
菌的に、滅菌した後述の組成の培地100 mlを含む
500 mlの三角フラスコ30本に一白金耳接種し・
22℃で、200 rpm(7cmの回転半径)のロー
タリー振どう培養機で5日間培養した。Example 1. Indanonaphthol B A) Cultured Hormonema sp. SANK 50190 strain was aseptically inoculated into 30 500 ml Erlenmeyer flasks containing 100 ml of a sterilized medium with the composition described below.
The cells were cultured at 22° C. for 5 days in a rotary shaking incubator at 200 rpm (7 cm radius of rotation).
培地組成
グルコース 10 gポリペプトン
5g
イースト・エキス 3g
麦芽エキス 3g
脱イオン水
1000 ml
pH5,6
B)単離
得られた培養液3Lにろ過動剤としてセライト545(
米国ジョーンズ・マンビル・プロジェクト・コーポレー
ション製) 100 gを加えてろ過を行い、菌体のケ
ーキを得た。得られた菌体のケーキに80%アセトン水
ILを加え、0.5時間攪拌しながら抽出した。同じ操
作を2回行い得られた抽出液2Lを、ロータリーエバポ
レーターで、減圧下アセトンを留去した。残留物に水を
加え500m1とした後、塩酸でpH3,0に調整し酢
酸エチル500 mlで2回抽出した。得られた酢酸エ
チル層をILの飽和食塩水で洗浄し、さらに無水硫酸ナ
トリウムで乾燥した後、ロータリーエバポレーターで減
圧下、濃縮乾固して500 mgの油状物を得た。Medium composition Glucose 10 g Polypeptone 5 g Yeast extract 3 g Malt extract 3 g Deionized water 1000 ml pH 5,6 B) Add Celite 545 (
(manufactured by Jones Manville Project Corporation, USA) was added and filtered to obtain a cake of bacterial cells. 80% acetone water (IL) was added to the obtained bacterial cell cake, and the mixture was extracted with stirring for 0.5 hours. The same operation was performed twice, and 2 L of the resulting extract was used to distill off acetone under reduced pressure using a rotary evaporator. Water was added to the residue to make 500 ml, the pH was adjusted to 3.0 with hydrochloric acid, and the mixture was extracted twice with 500 ml of ethyl acetate. The obtained ethyl acetate layer was washed with IL saturated brine, further dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure using a rotary evaporator to obtain 500 mg of an oil.
得られた油状物をシリカゲル20 gをメチレンクロリ
ドで充填したカラムに、同溶剤に溶解して吸着させ、次
いで、同一溶剤で展開溶出した。溶出液を15m1づつ
分画し、インダノナフトールBを含むフラクションNα
16〜19を集め減圧上濃縮乾固して黄色粗粉末100
mgを得た。黄色粗粉末100 mgは更に高速液体
クロマトグラフィー(センシューパックODS H−4
251(センシュー科学(株)製;溶離液、40%アセ
トニトリル)を用いて分取を行うと結晶状のインダノナ
フトールB80 mgが得られた。The obtained oil was dissolved in the same solvent and adsorbed on a column filled with 20 g of silica gel filled with methylene chloride, and then developed and eluted with the same solvent. The eluate was fractionated into 15ml portions, and the fraction Nα containing indanonaphthol B
Collect 16 to 19 and concentrate to dryness under reduced pressure to obtain 100 g of coarse yellow powder.
mg was obtained. 100 mg of yellow coarse powder was further subjected to high performance liquid chromatography (Senshu Pack ODS H-4).
251 (manufactured by Senshu Kagaku Co., Ltd.; eluent: 40% acetonitrile) to obtain 80 mg of crystalline indanonaphthol B.
実施例2.インダノナフトールAおよびBA)培養
ホルモネマ・エスピー・SANK 50190 株ヲ用
いて、実施例1.と同様に実施した。Example 2. Example 1. Indanonaphthol A and BA) Cultured Hormonema sp. SANK 50190 strain. It was carried out in the same way.
B)単離
得られた培養液2.5Lにろ過動剤としてセライト54
5(米国ジョーンズ・マンビル・プロジェクト・コーポ
レーション製) 100 gを加えてろ過を行い、ろ液
と菌体区分との分けた。菌体区分に80%アセトン水I
Lを加え室温下で1時間攪拌し抽出した。得られた抽出
液をろ過し、菌体と抽出ろ液に分けた。これをロータリ
ーエバポレーターで減圧下、アセトンを留去し水溶液5
00 mlを得た。得られた水溶液をpH3,0に調節
した後、500m1の酢酸エチルで2回抽出し、ILの
酢酸エチル層を得た。酢酸エチル層を飽和食塩水で洗浄
し、無水硫酸ナトリウムで乾燥後、ロータリーエバポレ
ーターで減圧下、濃縮乾固して油状物120 mgを得
た。一方、ろ液2.5Lは塩酸でPH3,0に調節し、
酢酸エチルIして2回抽出し2Lの酢酸エチル層を得た
。酢酸エチル層を飽和食塩水で洗浄し、無水硫酸ナトリ
ウムで乾燥後、ロータリーエバポレーターで減圧下、濃
縮乾固して油状物160 mgを得た。菌体区分および
ろ液より抽出して得た油状物を合わせて、合計280
mgの油状物を得た。得られた油状物を セファデック
スLH−2050gをメチレンクロリド:酢酸エチル(
1: 1)の溶剤で充填したカラムに同混合溶剤で溶解
して吸着させた。次いで、同一溶剤で展開溶出した。溶
出液を10 mlづつ分画しインダノナフトールAを含
むフラクションNα26〜30を集め減圧下、濃縮乾固
すると粉末のインダノナフトールA I3 mgが得ら
れた。インダノナフトールBはフラクションNα37〜
46に溶出され、その分画を集め減圧下、濃縮乾固する
と黄色粉末のインダノナフトールB40mgが得られた
。B) Celite 54 was added to 2.5 L of the isolated culture solution as a filtering medium.
5 (manufactured by Jones Manville Project Corporation, USA) was added and filtered to separate the filtrate and bacterial cells. 80% acetone water I for bacterial cell division
L was added thereto, and the mixture was stirred at room temperature for 1 hour and extracted. The obtained extract was filtered and separated into bacterial cells and extraction filtrate. The acetone was distilled off under reduced pressure using a rotary evaporator, and the aqueous solution 5
00 ml was obtained. After adjusting the resulting aqueous solution to pH 3.0, it was extracted twice with 500 ml of ethyl acetate to obtain an IL ethyl acetate layer. The ethyl acetate layer was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure using a rotary evaporator to obtain 120 mg of an oily substance. On the other hand, 2.5L of filtrate was adjusted to pH 3.0 with hydrochloric acid,
The mixture was extracted twice with ethyl acetate I to obtain a 2 L ethyl acetate layer. The ethyl acetate layer was washed with saturated brine, dried over anhydrous sodium sulfate, and then concentrated to dryness using a rotary evaporator under reduced pressure to obtain 160 mg of an oil. A total of 280
mg of oil was obtained. The obtained oil was mixed with Sephadex LH-2050g and methylene chloride:ethyl acetate (
It was dissolved in a column filled with a 1:1) solvent mixture and adsorbed. Then, it was developed and eluted with the same solvent. The eluate was fractionated into 10 ml portions, and fractions Nα26 to 30 containing indanonaphthol A were collected and concentrated to dryness under reduced pressure to obtain 3 mg of powdered indanonaphthol A. Indanonaphthol B is fraction Nα37~
46 was eluted, and the fractions were collected and concentrated to dryness under reduced pressure to obtain 40 mg of indanonaphthol B as a yellow powder.
(発明の効果)
以上から、本発明の新規化合物インダノナフトールAお
よびBは抗菌作用を示し、各種細菌に対する抗菌剤とし
て有用である。(Effects of the Invention) From the above, the novel compounds indanonaphthol A and B of the present invention exhibit antibacterial activity and are useful as antibacterial agents against various bacteria.
Claims (1)
およびその塩。 1)物質の性状:黄色粉末 2)分子式:C_1_9H_1_2O_6 3)分子量:336(FAB−MS法により測定)4)
元素分析:(%) 実測値C66.57H4.37 計算値C67.86H3.60 5)紫外線吸収スペクトル:λ_m_a_xnm(E^
1^%_1_c_m)メタノール中で測定した紫外線吸
収スペ クトルは、次に示す通りである。 232,260(sh),333,398 6)^1H−核磁気共鳴スペクトル:(δ:ppm)重
ジクロロメタン中、内部基準にテトラ メチルシランを使用して測定した核磁気共 鳴スペクトル(500MHz)は、次に示す通りである
。 5.01(1H,s)、6.84(1H,dd)、6.
86(1H,d)、6.93(1H,d)、6.94(
1H,d)、6.95(1H,d)、7.23(1H,
d)、7.57(1H,dd)、7.67(1H,dd
)、8.64(1H,s)、11.84(1H,s)7
)^1^3C−核磁気共鳴スペクトル:(δ:ppm)
重ジクロロメタン中、内部基準にテトラ メチルシランを使用して測定した核磁気共 鳴スペクトル(125.6MHz)は、次に示す通りで
ある。 66.60(d)、73.41(s)、114.57(
s)、116.62(d)、118.40(d)、11
8.84(d)、120.22(d)、122.82(
s)、126.62(d)、132.93(d)、13
7.73(s)、139.66(d)、140.13(
d)、151.03(s)、157.26(s)、16
3.22(s)、198.04(s)、198.36(
s)、8)溶解性: メタノール、エタノール、プロパノール、 ブタノール等のアルコール類、ジメチルス ルホキシド、ジメチルホルムアミド、クロ ロホルム、酢酸エチル、アセトン、エチル エーテルに可溶、n−ヘキサン、水に不溶。 9)呈色反応: 硫酸、ヨード、過マンガン酸カリウム、 塩化第二鉄反応に陽性。 10)薄層クロマトグラフィー: Rf値;0.54 吸着剤;シリカゲル(メルク社製、Art.5715) 展開溶剤;ジクロロメタン:メタノール =90:10 2、下記の式を有するインダノナフトールBおよびその
塩。 ▲数式、化学式、表等があります▼ 3、ホルモネマ属に属するインダノナフトールAおよび
B生産菌を培養し、その培養物より請求項1、および2
、記載のインダノナフトールAおよびBを採取すること
を特徴とする請求項1、および2、記載のインダノナフ
トールAおよびBの製法。 4、請求項3、において、ホルモネマ属に属するインダ
ノナフトールAおよびB生産菌がホルモネマ・エスピー
・SANK50190株(微工研菌寄第11359号、
FERMP−11359)である製法。[Claims] 1. Indanonaphthol A having the following physical and chemical properties
and its salt. 1) Properties of substance: yellow powder 2) Molecular formula: C_1_9H_1_2O_6 3) Molecular weight: 336 (measured by FAB-MS method) 4)
Elemental analysis: (%) Actual value C66.57H4.37 Calculated value C67.86H3.60 5) Ultraviolet absorption spectrum: λ_m_a_xnm (E^
1^%_1_c_m) The ultraviolet absorption spectrum measured in methanol is as shown below. 232,260 (sh), 333,398 6)^1H-Nuclear magnetic resonance spectrum: (δ: ppm) The nuclear magnetic resonance spectrum (500 MHz) measured in deuterated dichloromethane using tetramethylsilane as an internal standard is: It is as shown below. 5.01 (1H, s), 6.84 (1H, dd), 6.
86 (1H, d), 6.93 (1H, d), 6.94 (
1H, d), 6.95 (1H, d), 7.23 (1H,
d), 7.57 (1H, dd), 7.67 (1H, dd
), 8.64 (1H, s), 11.84 (1H, s) 7
)^1^3C-nuclear magnetic resonance spectrum: (δ:ppm)
The nuclear magnetic resonance spectrum (125.6 MHz) measured in deuterated dichloromethane using tetramethylsilane as an internal standard is as shown below. 66.60(d), 73.41(s), 114.57(
s), 116.62(d), 118.40(d), 11
8.84(d), 120.22(d), 122.82(
s), 126.62(d), 132.93(d), 13
7.73(s), 139.66(d), 140.13(
d), 151.03(s), 157.26(s), 16
3.22 (s), 198.04 (s), 198.36 (
s), 8) Solubility: Soluble in alcohols such as methanol, ethanol, propanol, butanol, dimethyl sulfoxide, dimethyl formamide, chloroform, ethyl acetate, acetone, ethyl ether, insoluble in n-hexane and water. 9) Color reaction: Positive for sulfuric acid, iodine, potassium permanganate, and ferric chloride reactions. 10) Thin layer chromatography: Rf value: 0.54 Adsorbent: Silica gel (manufactured by Merck & Co., Art. 5715) Developing solvent: dichloromethane:methanol = 90:10 2. Indanonaphthol B having the following formula and its salt . ▲There are mathematical formulas, chemical formulas, tables, etc.▼ 3. Indanonaphthol A and B producing bacteria belonging to the genus Hormonema are cultured, and claims 1 and 2 are obtained from the culture.
The method for producing indanonaphthol A and B according to claims 1 and 2, characterized in that indanonaphthol A and B described in . 4. In claim 3, the indanonaphthol A and B-producing bacteria belonging to the genus Hormonema are Hormonema sp.
FERMP-11359).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7967090A JPH03279379A (en) | 1990-03-28 | 1990-03-28 | New compound indanonaphthol a and b |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7967090A JPH03279379A (en) | 1990-03-28 | 1990-03-28 | New compound indanonaphthol a and b |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03279379A true JPH03279379A (en) | 1991-12-10 |
Family
ID=13696618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7967090A Pending JPH03279379A (en) | 1990-03-28 | 1990-03-28 | New compound indanonaphthol a and b |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03279379A (en) |
-
1990
- 1990-03-28 JP JP7967090A patent/JPH03279379A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100230961B1 (en) | Novel amimooligosaccharide derivative and process for preparing the same | |
JP2768829B2 (en) | Antibiotics | |
JPH03279379A (en) | New compound indanonaphthol a and b | |
EP0371762B1 (en) | New platelet activating factor antagonists, named "the phomactins", their preparation and use | |
JPH07278041A (en) | Antitumor substance be-24811 and its production | |
JP2803182B2 (en) | Antitumor substance BE-12233 | |
JPH041179A (en) | Antitumor substance be-14106 | |
JP2928626B2 (en) | Platelet activating factor antagonist formactin B | |
JPH03271284A (en) | New compound folipastatin | |
JP2826140B2 (en) | Platelet activating factor antagonist formactin A | |
JPH0449289A (en) | New compound apiodionen | |
JP2000086627A (en) | Antibacterial substance be-54476 and its production | |
JPH05255184A (en) | New compound ilicicolinic acid a or b | |
JPS6027390A (en) | Fr-900216 substance and its preparation | |
JPS61263971A (en) | Novel substance a300 | |
JPH0725878A (en) | Platelet aggregation inhibitor pi-334 | |
JPS5932120B2 (en) | Method for producing 9-β-D arabinofuranosyl adenine | |
JPH06135979A (en) | New substance nk374200, its production and use thereof | |
JPH06298752A (en) | Antitumor substance be-26668 and its production | |
JP2002212137A (en) | New antibiotics pasteurestin a and b, and method for producing the same | |
JPS6316391B2 (en) | ||
JPS60102190A (en) | Novel antibiotic ss9816e and its preparation | |
JPS59159786A (en) | New material argomycin | |
JPS62138196A (en) | Anthracyclin compound and production thereon | |
JPS58194848A (en) | Antibiotic, mycoplanesine d, its derivative and preparation thereof |